Doug Karriker was named Chief Financial Officer of Orgenesis Inc. As of November 14, 2026, Orgenesis Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 13, 2026, naming 2 appointments (Form 8-K, March 13, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Orgenesis Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Orgenesis Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-13. It names 2 people. Every row below is cited to the filing it comes from, and this page adds each new change as Orgenesis Inc. files it.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-03-13 | In | Director | 8-K, 2026-03-13 | ||
| 2026-03-13 | In | Chief Financial Officer | 8-K, 2026-03-13 |
Selling to them or working with them? See who runs Orgenesis Inc. now and the warning signs.
Free to see. No signup.
Watch Orgenesis Inc.
Get an email when Orgenesis Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Orgenesis Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Orgenesis Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Orgenesis Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Who leads Orgenesis Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Doug Karriker, appointed (filed 2026-03-13).
- Director: Adam Pelavin, appointed (filed 2026-03-13).
New leaders reset buying decisions — get the Full Report on Orgenesis Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Orgenesis Inc., with the record behind each one.
Find candidates like Director at Orgenesis Inc.Every change, in the filing's words
Appointed: Adam Pelavin, Director
In connection with Messrs. Pelavin's and Adler's election to the Board, [each director is entitled to receive an annual cash retainer of $30,000 and an annual grant of a stock option to purchase 625 shares for his service as a non-employee director of the Company pursuant to the Company's Director Compensation Policy.] Mr. Pelavin has been appointed to the audit committee of the corporation.
Appointed: Doug Karriker, Chief Financial Officer
On March 10, 2026, the Company appointed Doug Karriker as its Chief Financial Officer, effective March 10th,__, 2026.
- Election of Directors On March 10, 2026, the Board of Directors (the "Board") of the Company elected Adam Pelavin and Yaron Adler to serve immediately as members of the Board with a term expiring at the Company's 2026 annual meeting of stockholders and thereafter until his successor is duly elected and qualified, or until his earlier death, resignation or removal.
- In connection with the election of such directors to the Board, the Board also approved to fix the size of the Board at four members.
- Mr. Adler has been appointed to the compensation committee of the corporation.
- Neither Messrs. Pelavin or Adler have any family relations with any directors or executive officers of the Company.
- Mr. Karriker, [51], previously served as [Chief Financial Officer] at DataTech Global, LLC__________, a private company, from [2012 to September 2022].
Tools for this story
Each opens in a new tab, filled in for Orgenesis Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
